We are live on ! Find out more
INSY

Insys Therapeutics, Inc.
INSY

Delisted

INSY was delisted on the 18th of June, 2019.

Back to rankings

98 hedge funds and large institutions have $51.6M invested in Insys Therapeutics, Inc. in 2019 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 18 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 18

21% more capital invested

Capital invested by funds: $42.5M → $51.6M (+$9.09M)

13% less funds holding

Funds holding: 113 → 98 (-15)

42% less call options, than puts

Call options by funds: $724K | Put options by funds: $1.24M

45% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 29

Holders
98
Holders Change
-15
Holders Change %
-13.27%
% of All Funds
2.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
27
Reduced
18
Closed
29
Calls
$724K
Puts
$1.24M
Net Calls
-$517K
Net Calls Change
-$219K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$3.1M
2
Renaissance Technologies
Renaissance Technologies
New York
+$2.72M
3
Millennium Management
Millennium Management
New York
+$1.26M
4
PAM
Panagora Asset Management
Massachusetts
+$688K
5
Citadel Advisors
Citadel Advisors
Florida
+$480K

Top Sellers

Rank Fund Capital Flow
1
EMG
ETF Managers Group
New Jersey
-$5.08M
2
Norges Bank
Norges Bank
Norway
-$2.19M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$888K
4
BlackRock
BlackRock
New York
-$544K
5
JP Morgan Chase
JP Morgan Chase
New York
-$366K
Name Holding Trade Value Shares
Change 		Change in
Stake
CSS
101
Cubist Systematic Strategies
Connecticut
– -$134K -38,392 Closed
WMSA
102
Weiss Multi-Strategy Advisers
New York
– -$123K -35,000 Closed
BCM
103
Bridgeway Capital Management
Texas
– -$118K -33,800 Closed
ECM
104
Element Capital Management
New York
– -$99K -28,256 Closed
Tudor Investment Corp
105
Tudor Investment Corp
Connecticut
– -$88K -25,263 Closed
AQR Capital Management
106
AQR Capital Management
Connecticut
– -$83K -23,680 Closed
WAM
107
Weiss Asset Management
Massachusetts
– -$56K -16,140 Closed
PHK
108
Point72 Hong Kong
Hong Kong
– -$23K -6,607 Closed
BAM
109
Bruderman Asset Management
New York
– -$21K -5,934 Closed
SO
110
STRS Ohio
Ohio
– -$11K -3,200 Closed
Simplex Trading
111
Simplex Trading
Illinois
– -$5.09K -1,075 Closed
Toronto Dominion Bank
112
Toronto Dominion Bank
Ontario, Canada
– -$2K -680 Closed
MAM
113
Meeder Asset Management
Ohio
– -$2K -567 Closed
GT
114
Glenmede Trust
Pennsylvania
– -$1 -545 Closed
PCM
115
Prelude Capital Management
New York
– -$2K -486 Closed
GI
116
Gradient Investments
Minnesota
– -$2K -434 Closed
GSC
117
G&S Capital
Colorado
– -$1K -400 Closed
FGAM
118
Financial Gravity Asset Management
Texas
– +$237 +50 New
FRA
119
Front Row Advisors
California
– +$284 +60 New
1 2 3 4
5

INSY Hedge Fund Activity: Q1 2019 in Review

98 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Insys Therapeutics, Inc. (INSY) for Q1 2019, worth a combined $51.6M — up 21% from $42.5M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of INSY and 16 opened new positions — a net loss of 13 holders — while 18 trimmed existing stakes and 27 added.

The largest buyer was Vanguard Group, adding an estimated $3.1M. The largest seller was ETF Managers Group, exiting entirely with an estimated $5.08M sold.

  • 98 institutional investors held Insys Therapeutics, Inc. (INSY) as of Q1 2019, down from 113 in Q4 2018.
  • Funds reported $51.6M of Insys Therapeutics, Inc. stock for Q1 2019, up 21% quarter-over-quarter.
  • 16 funds opened new Insys Therapeutics, Inc. positions in Q1 2019 and 29 closed out, a net change of -13 holders.
  • The largest Insys Therapeutics, Inc. buyer in Q1 2019 was Vanguard Group, an estimated $3.1M added.
  • The largest Insys Therapeutics, Inc. seller in Q1 2019 was ETF Managers Group, an estimated $5.08M sold.

Based on aggregated 13F filings for Q1 2019.